北米のマリファナ株は,業界の成熟と,より強い競争者が出現するため,改善される見込みです. North American marijuana stocks are expected to improve due to industry maturation and emerging stronger competitors.
麻薬の生産は,北米の大麻産業が成熟するにつれて,将来的に改善される見込みです. Marijuana stocks are expected to improve in the future as the North American cannabis industry matures. 最近の不良な業績にもかかわらず,より強い競争者が登場し,業界のリーダーが収益性を持つことが期待されています. Despite recent poor performance, stronger competitors are emerging, and industry leaders are expected to become profitable. 拡大計画と国際成長見通しにより,Cronos Group,Tilray Brands,Curaleaf Holdingsなどの大麻株は潜在的な投資として特定されています. Cannabis stocks like Cronos Group, Tilray Brands, and Curaleaf Holdings are identified as potential investments due to their expansion plans and international growth prospects. しかし投資家は慎重に 収益性や成長に向けて前進している企業に 焦点を当てるべきです However, investors should be cautious and focus on businesses progressing towards profitability and growth.